title: [Expression of Mdr1 gene in a murine bone marrow transplantation model].
abstract: OBJECTIVE
  To investigate the expression of mdr1 gene in hematopoietic cells of a murine bone marrow transplantation model and to explore the feasibility of transferring mdr1 gene into hematopoietic cells to pro-vent myelosuppression from chemotherapy.
  
  
  METHODS
  mdr1 gene was transferred into hematopoietic cells of murine bone marrow by retrovirus vector. The expression and function of mdr1 gene in vivo was tested in a murine bone marrow transplantation model.
  
  
  RESULTS
  (1) mdr1 gene was successfully transferred into murine MNC, the transduction rate was 35%. (2) mdr1 gene transferred murine bone marrow transplantation model was established successfully by scheduled-bone marrow transplantation method. (3) In 1 approximately 5 months period, stable and effective expression of mdr1 gene could be detected in hematopoietic cells of the recipient mouse, the percentage of mdr1 gene expression cells in recipient's hematopoietic cells decreased monthly to 8.0%, 8.0%, 7.5%, 4.0% and 3.0%. (4) mdr1 expression hematopoietic cells had efficient resistance to chemotherapy.
  
  
  CONCLUSIONS
  It is an effective approach to transfer mdr1 gene into hematopoietic cells for preventing myelosuppression in chemotherapy.
authors.affiliation: General Surgery, The Children's Hospital of Chongqing Medical University, Chongqing 400014, China.
authors.forename: Quan
authors.initials: Q
authors.lastname: Kang
authors.forename: Xianqing
authors.initials: X
authors.lastname: Jin
authors.forename: Yingcun
authors.initials: Y
authors.lastname: Li
authors.forename: Shuhua
authors.initials: S
authors.lastname: An
authors.forename: Shan
authors.initials: S
authors.lastname: Wang
authors.forename: Jialing
authors.initials: J
authors.lastname: Xu
mesh_terms: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000235:genetics* / Q000378:metabolism; D000818:Animals; D000903:Antibiotics, Antineoplastic / Q000494:pharmacology; D000972:Antineoplastic Agents, Phytogenic / Q000494:pharmacology; D001854:Bone Marrow Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D016026:Bone Marrow Transplantation; D003630:Daunorubicin / Q000494:pharmacology; D018432:Drug Resistance, Multiple; D015870:Gene Expression; D005822:Genetic Vectors / Q000235:genetics; D006412:Hematopoietic Stem Cells / Q000166:cytology / Q000187:drug effects / Q000378:metabolism*; D007958:Leukocyte Count; D007963:Leukocytes, Mononuclear / Q000166:cytology / Q000187:drug effects / Q000378:metabolism; D051379:Mice; D008807:Mice, Inbred BALB C; D023421:Models, Animal; D017239:Paclitaxel / Q000494:pharmacology; D012190:Retroviridae / Q000235:genetics; D014162:Transfection
chemical_list: D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D000903:Antibiotics, Antineoplastic; D000972:Antineoplastic Agents, Phytogenic; D017239:Paclitaxel; D003630:Daunorubicin